QUEL Imaging awarded Phase II SBIR Contract by NCI
QUEL Imaging has begun work on a Phase II SBIR contract for the National Cancer Institute (NCI) of the National Institutes of Health (NIH) This highly competitive award provides funding over two years to develop bio-mimicking optical phantoms for advancing the field of fluorescence guided surgery. Read more in the full press release.
Join us this fall at the Advances in Optics for Biotechnology, Medicine and Surgery Conference
QUEL Imaging is sponsoring the ECI Conference happening October 15-19 in Tomar, Portugal. The primary goal of this conference aligns well with the mission of QUEL Imaging and will bring together world-leading scientists, engineers and clinicians involved in the clinical translation of optics to biotechnology, medicine, and surgery. Our CEO and co-founder will be giving a presnetation titled, "Tools to build consensus and accelerate clinical translation of intraoperative fluorescence imaging" Learn more and register at the conference website.
QUEL Imaging begins cooperative research agreement with NIST
QUEL Imaging and the National Institute of Standards and Technology (NIST) have entered into a Cooperative Research and Development Agreement (CRADA) titled, "Evaluation of Methods and Standards for Absorption Coefficient and Reduced Scattering Coefficient Measurements for Tissue-simulating Material". This collaboration aims to evaluate standardized methods and standards for optical property measurements (absorption coefficient and reduced scattering coefficient) of bio-mimicking phantom materials using spectrophotometric techniques.
See you at the 18th European Molecular Imaging Meeting | EMIM 2023
QUEL Imaging CEO and co-founder, Ethan LaRochelle will be attending EMIM 2023 and QUEL Imaging will be sponsoring the Standardization Study Group social evening. We're looking forward to connecting with our European collaborators and hearing your latest updates. If you haven't signed up, there's still time to join us
QUEL Imaging present in the San Francisco area
QUEL Imaging is co-sponsoring and presenting at the 2023 Stanford Symposium on Optical Surgical Navigation. In the days after this meeting, co-founders Ethan LaRochelle and Alberto Ruiz will be participating in SPIE Photonics West, where Dr. Ruiz will prsent, "Radiometric characterization methods for fluorescence guidance imaging systems using a calibrated solid-state emitter" and Dr. LaRochelle will discuss, "Advancing clinical reproducibility of intraoperative fluorescence imaging: analysis, metrics and multi-center equivalence"
QUEL Imaging CEO named Vermont Rising Star
Ethan LaRochelle was recognized by Vermont Business Magazine, VermontBiz, as one of 40 winners under the age of 40 for being, "outstanding young leaders chosen for contributions to the Vermont economy and their community." Read his full profile and see photos from the awards dinner at VermontBiz.
A new publication by the QUEL Imaging team
Ethan LaRochelle and the QUEL Imaging team had the article, "3D-Printed Tumor Phantoms for Assessment of in vivo Fluorescence Imaging Analysis Methods" accepted for publication in Molecular Imaging and Biology. This peer-reviewed publication stems from development efforts of a SBIR Phase I contract funded by the National Cancer Institute. The paper provides examples of how anthropomorphic phantoms can be used as reproducible tools to demonstrate image analysis techniques. Read the full article here.
QUEL Imaging attending WMIC 2022
Both Ethan LaRochelle and Alberto Ruiz will be attending WMIC 2022 in Miami at the end of September. QUEL Imaging is sponsoring the Optical Surgical Navigation Interest Group workshop and will have a booth in the exhibit hall. Please stop by and let us know how we can help you expedite the clinical translation of your fluorescence imaging technology.
QUEL Imaging awarded Phase II SBIR grant by NIBIB
QUEL Imaging has been awarded a highly competitive Small Business Innovation Research (SBIR) Phase II grant by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH). This funding will be used to continue development of fluorescence targets and tools supporting clinical translation of intraoperative fluorescence imaging systems. Read the full Press Release.
QUEL Imaging completes NIH I-Corps course
QUEL Imaging successfully completed the NIH I-Corps as an extension of their NCI SBIR Phase I contract. This opportunity required the participation of a team of three: co-founders Ethan LaRochelle (CEO, C-Level representative) and Alberto Ruiz (CTO, Technical lead), as well as an external collaborator, Mohit Ganguly (Business Mentor). The intensive 8-week course is designed to increase the team’s knowledge of market opportunities while also identifying potential funding opportunities. During this period the team interviewed over 100 stakeholders and conducted site visits to refine a hypothesis-driven Business Model Canvas.
If you missed us and would like to share your experiences with in vivo fluorescence imaging, please schedule a time to chat.
Ruiz defends PhD Thesis!
Congratulations to our CTO, Alberto Ruiz, for successfully defending his PhD thesis titled, "Fluorescence Imaging Guidance: Toward standardization and smartphone-based devices". Dr Ruiz presented his work to colleagues at the Thayer School of Engineering as well as family and friends over Zoom. His thesis committee was chaired by Dr. Kimberley Samkoe, and additional committee members were Scott Davis, Geoffrey Luke, and external examiner Jonathan Sorger of Intuitive Surgical.
QUEL Imaging will see you at the 17th European Molecular Imaging Meeting | EMIM 2022
March 15-18, 2022
QUEL Imaging will have a booth at EMIM 2022 in Thessaloniki, Greece. We're looking forward to participating in the conference and getting the latest updates on advancement in the imaging field. There is still time to register and join us! Please stop by our booth to discuss your application and learn how our targets and tools can advance your goals.
LaRochelle and Ruiz present at SPIE Photonics West
QUEL Imaging sponsored the Molecular Guided Surgery Conference at SPIE BiOS in San Francisco, CA. Our CEO, Ethan LaRochelle presented an industry perspective as part of this meeting, while our CTO, Alberto Ruiz presented updates on 3D-printing technologies in the Design and Quality for Biomedical Technologies meeting. Abstracts and presentations are available at:
QUEL Imaging awarded Phase I SBIR Contract by NCI
The National Cancer Institute of the National Institutes of Health recently awarded a highly-competitive Small Business Innovation Research (SBIR) Phase I contract to QUEL Imaging to develop bio-mimicking optical phantoms for advancing development of fluorescence guided surgical imaging systems. Read the full Press Release
QUEL Imaging participating in WMIC 2021 virtual conference
Alberto Ruiz will present a poster titled, "3D printed targets for fluorescence guided surgical systems" during the poster session on Thursday, October 7. QUEL Imaging will also have a booth in the virtual exhibitor hall, so please stop by to learn more about our latest products.
3D printing fluorescent material with tunable optical properties published in Scientific Reports
Alberto Ruiz, along with members of QUEL Imaging and their Dartmouth collaborators publish their latest research focused on 3D printing with different NIR fluorescence compounds. This work also describes how the team is able to tune optical properties to mimic tissue. Read the full article.
Ruiz presents 3D printing updates at 2021 SPIE BiOS
QUEL Imaging CTO, Alberto Ruiz gave two presentations describing the latest capabilities in 3D printing fluorescent material at the Molecular-Guided Surgery: Molecules, Devices and Design and Quality for Biomedical Technologies sessions.
QUEL Imaging awarded Phase I SBIR grant
QUEL Imaging LLC was awarded a grant by the National Institutes of Health for just over a quarter of a million US dollars. The concept for the grant funded by the NIBIB, stems from work in Ruiz’s studies developing 3D printed test targets for surgical system calibration. Read the full Press Release.
Ruiz is first author of publication describing fluorescence phantom development
With the growing adoption of fluorescence guided surgery using indocyanine green (ICG), there stands a need to characterize performance of various imaging systems. This paper describes a method of developing a solid ICG-equivalent reference phantom with long-term stability. Read more in this JBO publication.
Getting to know our CEO, Ethan LaRochelle
The Thayer School of Engineering at Dartmouth produces a video series called “I’m an Engineer and…”. In the latest edition they interview Ethan LaRochelle about his volunteer experience. Watch the video here.
LaRochelle defends his thesis over Zoom
Due to COVID-19 Ethan LaRochelle presented his thesis, “Modeling broad-spectrum light sources in vivo for applications in cancer treatment & diagnostics” from his home in Vermont. While non-traditional, this allowed for collaborators and participants from outside the Dartmouth community to easily join. A recording is available on YouTube.
LaRochelle’s submission featured on cover of March/April issue of Photochemistry and Photobiology
The dose modeling work highlighted in Photochemistry and Photobiology was selected to submit a cover image to the March/April issue. See the cover here.
Ruiz presents work at SPIE BiOS on developing characterization tools for fluorescence-guided imaging
One method QUEL Imaging aims to provide support for the field of optical surgical systems is through the development of innovative tools. Alberto Ruiz presented at SPIE BIOS on work describing the development and characterization of fluorescence phantoms. The founding members of QUEL Imaging also met with many in this industry during the conference, and presented on many other tangential topics.
Scottish Photobiology Unit highlights LaRochelle’s daylight dose model
Researchers at the Photobiology Unit of Ninewells Hospital in Dundee, Scotland described their experiences using the dose model for indoor daylight PDT. In a Highlight Article published in Photochemistry and Photobiology they describe the process as “very easy” obtaining results with the confidence intervals even as their measurements were performed on the other side of the Atlantic Ocean. Read more about their experience.
Ruiz has paper describing smartphone-based fluorescence imaging accepted to the Journal of Biomedical Optics
The dynamics of how the photosensitizer PpIX develops in skin lesions may help dermatologists tailor PDT treatments. Up until recently quantitative measurements required expensive bench-top equipment, but in this paper Ruiz describes how a smartphone can be used with a clip-on module to measure PpIX during PDT treatments of skin. Read the full paper here.
An interview with our co-founder and scientific advisor, Brian Pogue
The Magnuson Center for Entrepreneurship recently wrote about Brian Pogue’s experiences bringing biotech innovations to the market. Read more from his interview here.
QUEL Imaging awarded seed funding through the Quinn Innovation Scholars program
The founding members of QUEL Imaging pitched their idea for planning and monitoring daylight-activated photodynamic therapy of skin lesions using a smartphone. This competitive pitch process was reviewed by a board of advisors from the Norris Cotton Cancer Center and Tuck School of Business, among others. With the $20K in seed funding QUEL Imaging will further develop and test a prototype system.
LaRochelle publishes article on using weather for dose planning indoor daylight PDT of skin
Photochemistry and Photobiology published a research paper describing how complex Monte Carlo models of light fluence at depth in tissue could be simplified and combined with a site assessment and weather reports to estimate the photodynamic dose received by patients undergoing PDT treatments for skin lesions such as actinic keratosis. Read the full paper here.
LaRochelle and Ruiz present at the 17th International Photodynamic Association World Congress
Both Ethan LaRochelle and Alberto Ruiz presented in a session on Low-Cost Systems and Techniques in PDT Light Deliver, Dosimetry, and Treatment Guidance. Ruiz, gave an invited talk on smartphone-based dosimetry for individualization of PDT treatment planning, and LaRochelle presented the concept of using weather forecasts and light-tissue models for daylight PDT treatment planning.